Aberrant changes in growth factor processes can lead to abnormal cell growth and cancer and tumor formation. Malignancy can be triggered via the unregulated expression of growth factors and there corollary signaling pathways.
Different methods of targeting growth factor related cancer formation may be indicated including antagonists, monoclonal antibodies , receptor inhibitors, protein tyrosine kinase inhibition and cell transcription pathway interventions.
|
|
3D1.1 Antibody (Parathyroid hormone like protein) - Mouse Anti PTHLH
The protein encoded by this gene is a member of the parathyroid hormone family. This hormone regulates endochondral bone development and epithelial-mesenchymal interactions during the formation of the mammary glands and teeth. This hormone is involved in lactation possibly by regulating the mobilization and transfer of calcium to the milk. The receptor of this hormone, PTHR1, is responsible for most cases of humoral hypercalcemia of malignancy. Four alternatively spliced transcript variants encoding two distinct isoforms have been observed. There is also evidence for alternative translation initiation from non-AUG (CUG and GUG) start sites, in-frame and downstream of the initiator AUG codon, to give rise to nuclear forms of this hormone
£226.00
Insulin Like Growth Factor Antibody - Mouse Anti-Insulin Like Growth Factor (IGF-1)
Insulin is a pancreatic hormone that regulates glucose uptake and the synthesis of protein and fat. The insulin like growth factors, isolated from plasma, are structurally and functionally related to insulin but have a much higher growth promoting activity. IGF1 (Insulin Like Growth Factor I) is a polypeptide growth factor, which stimulates the proliferation of a wide range of cell types including muscle, bone, and cartilage tissue. IGF1 functions as an autocrine regulator of growth
£226.00
TGF beta Antibody- Mouse Anti-Human TGF beta
TGFB is a multifunctional peptide that controls proliferation differentiation and other functions in many cell types TGFB acts synergistically with TGFA (MIM 190170) in inducing transformation It also acts as a negative autocrine growth factor Dysregulation of TGFB activation and signaling may result in apoptosis Many cells synthesize TGFB and almost all of them have specific receptors for this peptide TGFB1 TGFB2 (MIM 190220) and TGFB3 (MIM 190230) all function through the same receptor signaling systems
£226.00
